11β-hydroxylase deficiency screening

	Congenital adrenal hyperplasia main page
	11β-hydroxylase deficiency Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 11β-hydroxylase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
11β-hydroxylase deficiency screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 11β-hydroxylase deficiency screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 11β-hydroxylase deficiency screening
CDC on 11β-hydroxylase deficiency screening
11β-hydroxylase deficiency screening in the news
Blogs on 11β-hydroxylase deficiency screening
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Risk calculators and risk factors for 11β-hydroxylase deficiency screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

According to the CARES Foundation guidlines, screening for 11β-hydroxylase deficiency is not recomended.^[1]

According to the CARES Foundation guidlines, screening for 11β-hydroxylase deficiency is not recomended.^[1]

↑ ^1.0 ^1.1 Auchus RJ, Witchel SF, Leight KR, Aisenberg J, Azziz R, Bachega TA, Baker LA, Baratz AB, Baskin LS, Berenbaum SA, Breault DT, Cerame BI, Conway GS, Eugster EA, Fracassa S, Gearhart JP, Geffner ME, Harris KB, Hurwitz RS, Katz AL, Kalro BN, Lee PA, Alger Lin G, Loechner KJ, Marshall I, Merke DP, Migeon CJ, Miller WL, Nenadovich TL, Oberfield SE, Pass KA, Poppas DP, Lloyd-Puryear MA, Quigley CA, Riepe FG, Rink RC, Rivkees SA, Sandberg DE, Schaeffer TL, Schlussel RN, Schneck FX, Seely EW, Snyder D, Speiser PW, Therrell BL, Vanryzin C, Vogiatzi MG, Wajnrajch MP, White PC, Zuckerman AE (2010). "Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative". Int J Pediatr Endocrinol. 2010: 275213. doi:10.1155/2010/275213. PMC 3025377. PMID 21274448.